Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Valbenazine Improves Quality of Life, Functionality, and Movement Severity in Patients With Tardive Dyskinesia: Findings From the KINECT-PRO™ Study.
Journal: CNS spectrums
Published: August 10, 2026
Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: October 23, 2025
The PARCS Pilot Study Randomized Controlled Trial: Feasibility and Acceptability of a Park-Based Exercise Program Led by Peer Specialists for Peers with Serious Mental Illness.
Journal: Journal of healthy eating and active living
Published: September 05, 2025
Childhood Trauma in People with Psychosis: Implications for Emotion Awareness and Regulation.
Journal: Psychosis
Published: August 26, 2025
Insomnia and substance use in psychotic disorders.
Journal: Schizophrenia research
Published: May 12, 2025
Telehealth-Based vs In-Person Aerobic Exercise in Individuals With Schizophrenia: Comparative Analysis of Feasibility, Safety, and Efficacy.
Journal: JMIR mental health
Published: November 07, 2024
Tardive dyskinesia versus tardive syndrome. What is in a name?
Journal: Parkinsonism & related disorders
Published: October 09, 2024
Improved insomnia is one pathway underlying the anti-suicidal properties of clozapine.
Journal: Suicide & life-threatening behavior
Published: February 16, 2024
Meta-analysis of clozapine and insomnia in schizophrenia.
Journal: Schizophrenia research
Published: July 13, 2022
Lower adiponectin levels as a predictor of depressive symptoms in African-American males with schizophrenia.
Journal: Schizophrenia research
Published: July 12, 2022
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.
Journal: BMC psychiatry
Published: November 29, 2021
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.
Journal: CNS drugs
Published: August 23, 2021
Last Updated: 09/26/2026